High-density lipoprotein cholesterol in diabetes: Is higher always better?

Journal of Clinical Lipidology

Volumn 5, Issue 5, 2011, Pages 387-394

  Costacou, Tina ^a   Evans, Rhobert W ^a   Orchard, Trevor J ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Coronary artery disease; Gender; HDL cholesterol; Type 1 diabetes

Indexed keywords

DEXTRAN SULFATE; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MANGANESE;

ADULT; ANGINA PECTORIS; ANGIOGRAPHY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HAZARD RATIO; HEART DEATH; HEART INFARCTION; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRECIPITATION; PRIORITY JOURNAL; REVASCULARIZATION; SEX DIFFERENCE; STENOSIS;

ADOLESCENT; ADULT; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RISK FACTORS; SEX FACTORS;

ANGINA;

EID: 80053904635     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.06.011     Document Type: Article

References (32)

1. P.J. Barter, M. Caulfield, and M. Eriksson ILLUMINATE Investigators. Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122 (Pubitemid 350146106)
2. J.J. Kastelein, S.I. van Leuven, and L. Burgess RADIANCE 1 Investigators. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia N Engl J Med 356 2007 1620 1630 (Pubitemid 46631671)
3. S.E. Nissen, J.C. Tardif, and S.J. Nicholls ILLUSTRATE Investigators. Effect of torcetrapib on the progression of coronary atherosclerosis N Engl J Med 356 2007 1304 1316 (Pubitemid 46513296)
4. M. Vergeer, M.L. Bots, S.I. van Leuven, and D.C. Basart Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials Circulation 118 2008 2515 2522
5. S.J. Nicholls, E.M. Tuzcu, D.M. Brennan, J.C. Tardif, and S.E. Nissen Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation) Circulation 118 2008 2506 2514
6. M. Briel, I. Ferreira-Gonzalez, and J.J. You Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis BMJ 338 2009 b92
7. W.A. van der Steeg, I. Holme, and S.M. Boekholdt High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies J Am Coll Cardiol 51 2008 634 642 (Pubitemid 351186873)
8. B.A. van Acker, G.J. Botma, and A.H. Zwinderman REGRESS Study Group. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants Atherosclerosis 200 2008 161 167
9. T.J. Orchard Dyslipoproteinemia and diabetes Endocrinol Metab Clin North Am 19 1991 361 380 (Pubitemid 20188280)
10. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study Am J Med 62 1977 707 714 (Pubitemid 8110784)
11. N.E. Miller, D.S. Thelle, O.H. Forde, and O.D. Mjos The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study Lancet 1 1977 965 968
12. D.J. Gordon, J.L. Probstfield, and R.J. Garrison High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 79 1989 8 15 (Pubitemid 19043669)
13. T.J. Orchard, J.C. Olson, and J.R. Erbey Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study Diabetes Care 26 2003 1374 1379 (Pubitemid 36929165)
14. A. Juutilainen, S. Kortelainen, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso Gender difference in the impact of type 2 diabetes on coronary heart disease risk Diabetes Care 27 2004 2898 2904 (Pubitemid 39565056)
15. R.C. Turner, H. Millns, and H.A. Neil Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ 316 1998 823 828 (Pubitemid 28112428)
16. S.S. Soedamah-Muthu, Y.F. Chang, J. Otvos, R.W. Evans, and T.J. Orchard Pittsburgh Epidemiology of Diabetes Complications Study. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study Diabetologia 46 2003 674 682 (Pubitemid 36808187)
17. T.J. Orchard, J.S. Dorman, and R.E. Maser Prevalence of complications of IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II Diabetes 39 1990 1116 1124 (Pubitemid 20263324)
18. D.K. Wagener, J.M. Sacks, R.E. LaPorte, and J.M. MacGregor The Pittsburgh Study of insulin-dependent diabetes mellitus: risk for diabetes among relatives of IDDM Diabetes 31 1982 136 144 (Pubitemid 12223965)
19. N.O. Borhani, E.H. Kass, H.G. Langford, G.H. Payne, R.D. Remington, and J. Stamler The hypertension detection and follow-up program Prev Med 5 1976 207 215
20. G.R. Warnick, and J.J. Albers Heparin-Mn2+ quantitation of high density lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples Clin Chem 24 1978 900 904 (Pubitemid 8357903)
21. National Institutes of Health and Department of Health Lipid Research Clinics Program 1975 U.S. Government Printing Office Washington, DC
22. L.I. Gidez, G.J. Miller, M. Burstein, S. Slagle, and H.A. Eder Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure J Lipid Res 23 1982 1206 1223 (Pubitemid 13187618)
23. C.C. Allain, L.S. Poon, C.S.G. Chan, W. Richmond, and P.C. Fu Enzymatic determination of total serum cholesterol Clin Chem 20 1974 470 475
24. G. Bucolo, and H. David Quantitative determination of serum triglycerides by the use of enzymes Clin Chem 19 1973 476 482
25. S.G. Mendoza, A. Zerpa, and H. Carrasco Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol and lipolytic enzymes in men with premature myocardial and angiographically assessed coronary occlusion Artery 12 1983 1 23 (Pubitemid 14123137)
26. E.A. Stein, L. Dipersio, and A.J. Pesce Enzyme-linked immunoabsorbent assay of apolipoprotein AII in plasma with use of monoclonal antibody Clin Chem 32 1986 967 971 (Pubitemid 17021158)
27. D. Ellis, and G.J. Buffone A new approach to the evaluation of proteinuric states Clin Chem 23 1977 666 670 (Pubitemid 8073594)
28. T.J. Orchard, T. Costacou, A. Kretowski, and R.W. Nesto Type 1 diabetes and coronary artery disease Diabetes Care 29 2006 2528 2538 (Pubitemid 44912266)
29. B.F. Asztalos, and E.J. Schaefer High-density lipoprotein subpopulations in pathologic conditions Am J Cardiol 91 Suppl. 2003 12E 17E (Pubitemid 36385070)
30. A.R. Tall Cholesterol efflux pathways and other potential mechanisms involved in the atheroprotective effect of high density lipoproteins J Intern Med 263 2008 256 273 (Pubitemid 351207349)
31. J.R. Nofer, B. Kehrel, M. Fobker, B. Levkau, G. Assmann, and A. von Eckardstein HDL and arteriosclerosis: beyond reverse cholesterol transport Atherosclerosis 161 2002 1 16 (Pubitemid 34214816)
32. R.J. Bisoendial, G.K. Hovingh, J.H.M. Levels, P.G. Lerch, I. Andresen, M.R. Hayden, J.J.P. Kastelein, and E.S.G. Stroes Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein Circulation 107 2003 2944 2948 (Pubitemid 36736637)